3
Announcements
Trials
Browse
Landscape
Status
Terminated
1
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Plasma cell
2
Lymphoid
1
CNS
1
Conditions
Spondylolisthesis
1
Spinal Stenosis
1
Spinal Cord Neoplasms
1
Intervertebral Disc Displacement
1
Intervertebral Disc Degeneration
1
Failed Back Surgery Syndrome
1
Interventions
Temozolomide
80
Radiotherapy
41
Bevacizumab
35
Radiosurgery
23
Magnetic Resonance Spectroscopy
20
Cyclophosphamide
17
Radiation
14
Irinotecan
13
Carboplatin
12
Topotecan
11
Nivolumab
11
Lomustine
11
Filgrastim
10
Everolimus
10
Etoposide
10
Erlotinib Hydrochloride
10
pembrolizumab
9
Radiotherapy, Intensity-Modulated
9
Ipilimumab
9
Granulocyte Colony-Stimulating Factor
8
Carmustine
8
antineoplaston AS 2-1
7
antineoplaston A10
7
Surgical Procedures, Operative
7
Mental Status and Dementia Tests
7
Isotretinoin
7
Granulocyte-Macrophage Colony-Stimulating Factor
7
sargramostim
6
Vincristine
6
TPI-287
6
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Terminated
×
Transplantation, Autologous
×
CNS
×
Clear all
NCT00974623
2017-04-05
APPROACH-001
Baxter Healthcare Corporation
Terminated
329 enrolled